&noscript=1""/>

Study Shows A1c Control Leading to Cost Savings

 

Read More

 

 

Delivering care virtually to at-risk populations is more important than ever during the COVID-19 pandemic. People with underlying conditions have been shown to be more vulnerable to serious COVID-19 symptoms: one study of COVID-19 patients showed that nearly 20% of those hospitalized had diabetes. Lark's Virtual Diabetes Management Program (DMP) shows clinically validated results at 4 months.

How Much Can Lark's DMP Save You?

In this paper, we describe how a digital, infinitely scalable, standalone solution can drive population benefits among people with type 2 diabetes. As the nation continues to contend with the coronavirus (COVID-19) outbreak, it’s important to remember that there is another health crisis facing the country that is exacerbating the effects of COVID-19: Chronic diseases such as diabetes.